Page 10 - Lab Central News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aldatu Begins Offering COVID-19 Testing Services for Health Care Providers, Employers and Schools Share Article Boston-area Firm Offers Rapid Turnaround of Diagnostic Tests “COVID-19 presents unique diagnostic testing challenges,” said Iain MacLeod, Ph.D., co-founder and CEO of Aldatu. “Our PANDAA™ platform has demonstrated it can work with the new SARS-CoV-2 variants with no loss of sensitivity and specificity.” WATERTOWN, Mass. (PRWEB) February 25, 2021 Aldatu Biosciences, the leader in adaptive PCR diagnostics, anno...

Share this article Share this article CAMBRIDGE, Mass., Feb. 18, 2021 /PRNewswire/ -- LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Thermo Fisher Scientific and Waters Corporation join Astellas and the Massachusetts Life Sciences Center (MSLC) as sponsors. Part of the Massachusetts Institute of Technology's (MIT) South of Main Street (SoMa) Develo...

Editas Medicine  James Mullen takes over as CEO from Feb. 15. Editas chairman Mullen will don the CEO mantle Feb. 15, taking over for current Editas chief Cynthia Collins. Before jumping to the Editas team, Mullen was CEO and director of the CDMO Patheon—later snapped up by Thermo Fisher—and also served as the CEO of Biogen. In a brief release, Editas didn’t say why Collins was leaving. “It has been a privilege to lead Editas Medicine and this extremely talented team,” she said in a statement. “I am particularly proud of the progress to the clinic we have made with both in vivo...

Golden Tickets winners Bolden Therapeutics and Seranova Bio will have access to a state-of-the-art lab facilities at LabCentral with mentorship and support from Biogen CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and LabCentral today announced Bolden Therapeutics and Seranova Bio as the recipients of Biogen’s Golden Tickets, an initiative offering promising winning startups one year of lab space accompanied by continued mentorship from Biogen. LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-scien...

Share this article Share this article CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/ -- LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced LabCentral Ignite, a new initiative with the goal of enhancing regional biotech innovation by stimulating a robust pipeline of diverse, qualified talent. Through internal programming and grants to non-profits focused on STEM education, workforce training and entrepreneurial development, LabCentral Ignite will facilitate broader access to the biotech industry, with emphasis o...